In recent years, several novel aspects of GPCR pharmacology have been described, which are thought to play a role in determining the in vivo efficacy of a compound. Fluorescent ligands have been used to study many of these, which have also required the development of new experimental approaches. Fluorescent ligands offer the potential to use the same fluorescent probe to perform a broad range of experiments, from single-molecule microscopy to in vivo BRET. This review provides an overview of the in vitro use of fluorescent ligands in further understanding emerging pharmacological paradigms within the GPCR field, including ligand-binding kinetics, allosterism and intracellular signalling, along with the use of fluorescent ligands to study physiologically relevant therapeutic agents.
© 2019 The British Pharmacological Society.
Conflict of interest statement
The authors declare no conflicts of interest.
Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding.Br J Pharmacol. 2016 Oct;173(20):3028-37. doi: 10.1111/bph.13316. Epub 2015 Nov 5. Br J Pharmacol. 2016. PMID: 26317175 Free PMC article. Review.
Fluorescent GPCR ligands as new tools in pharmacology-update, years 2008-early 2014.Curr Med Chem. 2014;21(34):3962-75. doi: 10.2174/0929867321666140826120058. Curr Med Chem. 2014. PMID: 25174921 Review.
Fluorescent GPCR ligands as new tools in pharmacology.Curr Med Chem. 2008;15(21):2132-43. doi: 10.2174/092986708785747599. Curr Med Chem. 2008. PMID: 18781940 Review.
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2. Phys Biol. 2013. PMID: 23912807
Probing the pharmacology of G protein-coupled receptors with fluorescent ligands.Neuropharmacology. 2015 Nov;98:48-57. doi: 10.1016/j.neuropharm.2015.04.033. Epub 2015 May 13. Neuropharmacology. 2015. PMID: 25979488 Review.